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Introduction: Epicardial adipose tissue (EAT), accumulated around the heart, is considered an index of 
visceral adiposity and a promising indicator of high cardio-metabolic risk. Evidences showing that EAT is a 
metabolically active organ and a source of inflammatory adipo-chemocytokines suggest a condition of 
chronic inflammation in this small cardiac fat depot. However, the potential links between cardiac adiposity 
and circulating levels of inflammatory adipo-chemokines, as markers of subclinical inflammation, are not 
completely understood. 
Our aim is to evaluate whether cardiac adiposity, measured as EAT thickness, is related to Regulated on 
activation, Normal T Cell Expressed and Secreted (RANTES/CCL5) levels, in obese patients. 
Methods: EAT thickness (meauserd by echocardiography, on the free wall of right ventricle), 
RANTES/CCL5 and other inflammatory markers (by ELISA kit) were measured in 36 women with 
uncomplicated obesity (OB) (BMI 41.6±5.6 kg/m2) and 15 normal-weight controls. Abdominal visceral 
adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were assessed by computed tomography (CT). 
Results: OB patients had thicker EAT (6.8±0.9 vs. 1.3±0.3 mm, p<0.0001) (Fig.1) and higher 
RANTES/CCL5 levels (2468.9±745.5 vs. 1272.1±413.7 pg/ml, p<0.03) than controls (Fig. 2). The EAT 
thickness positively correlated with RANTES/CCL5 concentrations (r2=0.65, p<0.001) (Fig.3). Moreover, 
EAT thickness and RANTES/CCL5 concentration were directly correlated with indices of fat distribution 
(VAT, VAT/SAT and waist, p<0.001 for all). Notably, when using multiple regression analysis, 
RANTES/CCL5 levels most closely correlated with EAT thickness (t=3.93) and VAT areas (t=3.77), while 
other indices of fat distribution did not enter the model. 
Conclusions: EAT thickness, an indicator of cardiac adiposity, may be related to inflammatory adipo-
chemokines in visceral-obese patients and might be used as a reliable marker of visceral adiposity. The 
elevated RANTES/CCL5 levels, contributing to the pro-inflammatory state, may also lead to cardio-
metabolic disorders. 
 
 
